During the past decade, School of Pharmacy CUHK conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "School of Pharmacy CUHK" are "Rheumatoid Arthritis" (1 trials) and "Systemic Lupus Erythematosus" (1 trials). Many other conditions were trialed in "School of Pharmacy CUHK" in a lesser frequency.

Most popular intervention types in "School of Pharmacy CUHK" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ibandronate+alfacalcidol+calcium" (1 trials), "Placebo" (1 trials), "Rosuvastatin" (1 trials) and "placebo ibandronate+alfacalcidol+calcium" (1 trials). Other intervention names were less common.

The vast majority of trials in "School of Pharmacy CUHK" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "School of Pharmacy CUHK". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in School of Pharmacy CUHK, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in School of Pharmacy CUHK, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".